Rode W, Leś A
M. Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Acta Biochim Pol. 1996;43(1):133-42.
Thymidylate synthase is a target enzyme in anticancer, antiviral, antifungal and antiprotozoan chemotherapy. With two dUMP analogues, 5-fluoro-dUMP (FdUMP) and 5-(trifluoromethyl)-dUMP (CF3dUMP), strong thymidylate synthase inhibitors and active forms of drugs, the inhibition mechanism is based on the reaction mechanism. Recent comparative studies of new dUMP analogues, containing more than one substituent in the pyrimidine ring, showed that substitution of the pyrimidine ring C(4) = O group in FdUMP by either C(4) = N-OH group (in N4-hydroxy-FdCMP) or C(4) = S group (in 4-thio-FdUMP) preserves high inhibitory potency of the drug but may alter its specificity for thymidylate synthases from various sources, which differ in sensitivity to slow-binding inhibition by FdUMP. Informations suggesting mechanisms responsible for the foregoing have been reviewed, including results of molecular modeling studies suggesting interaction of the pyrimidine C(4) = O group, or its modification, with the N5,10-methylene.(ABSTRACT TRUNCATED)
胸苷酸合成酶是抗癌、抗病毒、抗真菌和抗原虫化疗中的一种靶酶。5-氟-dUMP(FdUMP)和5-(三氟甲基)-dUMP(CF3dUMP)这两种dUMP类似物是强力胸苷酸合成酶抑制剂及药物的活性形式,其抑制机制基于反应机理。近期对嘧啶环中含有多个取代基的新型dUMP类似物的比较研究表明,FdUMP中嘧啶环的C(4)=O基团被C(4)=N-OH基团(在N4-羟基-FdCMP中)或C(4)=S基团(在4-硫代-FdUMP中)取代后,药物仍保持高抑制效力,但可能会改变其对不同来源胸苷酸合成酶的特异性,这些胸苷酸合成酶对FdUMP的慢结合抑制的敏感性不同。已对提示上述现象机制的信息进行了综述,包括分子建模研究结果,这些结果表明嘧啶C(4)=O基团或其修饰与N5,10-亚甲基之间存在相互作用。(摘要截选)